FDA Clears First Gene Therapy for Rare Glycogen Disorder
WASHINGTON, D.C. — The Food and Drug Administration last week granted accelerated approval to Ultragenyx Pharmaceutical Inc.’s Genglycos, the first treatment for glycogen storage disease type Ia, after a clinical …
FDA Clears First Gene Therapy for Rare Glycogen Disorder Read More